Skip to main contentAI and Advanced
/
GKSL · NSEBSE SENSEX76,132.81-0.50%BSE |
NIFTY 5023,779.15-0.50%NSE |
NIFTY BANK57,088.3-0.49%NSE |
NIFTY IT29,995.2-2.28%NSE |
NIFTY AUTO27,698.75-0.04%NSE |
NIFTY FMCG45,592.15-0.66%NSE |
NIFTY PHARMA26,675.5+0.75%NSE |
NIFTY 50023,156.2-0.42%NSE |
GK
NSE · Equity shares · Healthcare Facilities3.53 · 2.04%
Gujarat Kidney and Super Speciality Ltd GKSL
NSE:INR 176.34
BSE:INR 177.8
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for GKSL
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 172.81
Day rangeINR 172.83 — INR 177.9
52-week rangeINR 98.25 — INR 177.9
Volume3.82 L
Market cap1,010.37
P/E47.44
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)82.01
Net Income (INR Cr)15.5
Rev Growth (5 Year %)136.75
EPS Growth (5 Year %)198.82
P/E Ratio47.44
Book Value20.52
EPS2.49
Price/BV8.59Computed
Research path: Interpret Gujarat Kidney and Super Speciality Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
GKSLGujarat Kidney and Super Speciality Ltd1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 297.64 | 55.34 | 20.53 |
| Other Liabilities Total | 0.88 | 0.5 | 0.26 |
| Accrued Expenses | 0.19 | 0.58 | 0.4 |
| Long Term Debt | 1.79 | 2.14 | 1.53 |
| Common Stock Total | 15.77 | 11.37 | 0.2 |
| Other Current Assets Total | 1.99 | 0.8 | 0 |
| Total Assets | 297.64 | 55.34 | 20.53 |
| Current Portof LT Debt/Capital Leases | 14.89 | 0.99 | 0.64 |
| Cash | 13.28 | 2.6 | 0.97 |
| Total Equity | 252.51 | 25.94 | 10.8 |
| Long Term Investments | 2.94 | 1.59 | 0 |
| Retained Earnings(Accumulated Deficit) | 236.74 | 9.64 | 1.54 |
| Total Common Shares Outstanding | 7.88 | 7.88 | 7.88 |
| Tangible Book Valueper Share Common Eq | 20.52 | 2.39 | 1.37 |
| Goodwill Net | 90.73 | 7.13 | 0 |
| Total Liabilities | 45.13 | 29.41 | 9.72 |
| Total Debt | 29.11 | 8.31 | 5.87 |
| Short Term Investments | 46.21 | 0.21 | 0.2 |
| Cashand Short Term Investments | 59.49 | 2.81 | 1.18 |
| Total Receivables Net | 41.06 | 15.35 | 4.93 |
| Accounts Receivable-Trade Net | 38.63 | 15.16 | 4.2 |
| Property/Plant/Equipment Total-Net | 37.78 | 23.88 | 13.64 |
| Minority Interest | 2.22 | 1.19 | Not available |
| Total Current Liabilities | 27.81 | 21.69 | 4.24 |
| Total Inventory | 2.06 | 0.68 | 0.27 |
| Accounts Payable | 8.46 | 3.25 | 2.19 |
| Other Currentliabilities Total | 4.27 | 15.58 | 1 |
| Total Long Term Debt | 14.21 | 6.03 | 5.23 |
| Other Long Term Assets Total | 61.61 | 0.9 | 0.16 |
| Total Current Assets | 104.59 | 21.84 | 6.73 |
| Capital Lease Obligations | 12.43 | 3.88 | 3.7 |
| Accumulated Depreciation Total | Not available | -6.03 | -0.32 |
| Other Equity Total | Not available | 0.09 | 0 |
| Prepaid Expenses | Not available | 2.21 | 0.35 |
| Additional Paid-In Capital | Not available | 4.84 | 9.06 |
| Property/Plant/Equipment Total-Gross | Not available | 29.92 | 13.96 |
| Notes Payable/Short Term Debt | Not available | 1.29 | 0 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio0.31
Price to Sale Ratio12.32
Margins
Operating Margin 12m27.12
Operating Margin 5y Avg28.74
Net Profit Margin 12m20.5
Net Profit Margin 5y22.14
Yield
Dividend Yield %0
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk31.27
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,899.85 | 1.28 L | 65.51 | — |
| Max Healthcare Institute | INR 1,084.65 | 1.06 L | 72.29 | — |
| Fortis Healthcare | INR 950.7 | 71,703.64 | 67.89 | — |
| Aster DM Healthcare | INR 801.4 | 41,280.96 | 101.96 | — |
| Narayana Hrudayalaya | INR 1,965.35 | 40,007.75 | 47.98 | — |
Shareholding
Ownership
- Promoter
- 71.45%
- FII
- 4.89%
- Other
- 23.66%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Concerns Surrounding Gujarat Kidney And Super Speciality's (NSE:GKSL) Performance - simplywall.stMarket news · 5 Jun 2026, 9:03 am
Concerns Surrounding Gujarat Kidney And Super Speciality's (NSE:GKSL) Performance simplywall.st
Gujarat Kidney seeks nod to vary IPO proceeds utilization - scanx.tradeMarket news · 4 Jun 2026, 1:31 pm
Gujarat Kidney seeks nod to vary IPO proceeds utilization scanx.trade
Gujarat Kidney & Super Speciality Ltd Quality Parameters Upgrade: A Detailed Fundamental Analysis - Markets MojoMarket news · 4 Jun 2026, 12:18 am
Gujarat Kidney & Super Speciality Ltd Quality Parameters Upgrade: A Detailed Fundamental Analysis Markets Mojo
M&A boom sweeps Gujarat’s pvt healthcare market - MSNMarket news · 3 Jun 2026, 5:35 pm
M&A boom sweeps Gujarat’s pvt healthcare market MSN
Gujarat Kidney & Super Speciality Ltd Sees Technical Momentum Shift Amid Mixed Market Signals - Markets MojoMarket news · 3 Jun 2026, 11:36 am
Gujarat Kidney & Super Speciality Ltd Sees Technical Momentum Shift Amid Mixed Market Signals Markets Mojo
Gujarat Kidney & Super Speciality Ltd is Rated Hold - Markets MojoMarket news · 2 Jun 2026, 3:00 am
Gujarat Kidney & Super Speciality Ltd is Rated Hold Markets Mojo
Corporate actions
Events
- annual General MeetingPOM
- board MeetingsAudited Results
- annual General MeetingPOM
- board Meetings(Revised)
- board MeetingsQuarterly Results
ShareKeyX Community
Discussion and sentiment for Gujarat Kidney and Super Speciality Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Gujarat Kidney and Super Speciality Ltd is a regional healthcare company. The Company operates a chain of mid-sized multispecialty hospitals, providing integrated healthcare services, with a focus on secondary and tertiary care. The Company offers a comprehensive range of healthcare services, such as General Medicine, General Surgery, Laparoscopic Surgery, Metabolic and Obesity Surgery, In vitro fertilization (IVF), Obstetrics and Gynecology (OBGY), Ortho, Joint Replacement, Arthroscopy, Endocrinology, Diabetology, Pulmonology, Intensivist, Skin and VD, Radiology, Pathology, Psychiatrist, Pediatric, Ophthalmology, ear, nose, and throat (ENT), Physiotherapy, Dietician, Urology, Cardiology, Nephrology, Neurology, Neuro Surgery, Oncology, Onco Surgery, Renal Transplant, Vascular Surgery, Gastroenterology, Gastro Surgery, Plastic Surgery, and Pediatric Surgery. The Company operates seven multi-specialty hospitals and four pharmacies within its hospitals.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- GKSL
- BSE Code
- 544666
Questions
Stock FAQ
What is the symbol and ISIN of Gujarat Kidney and Super Speciality Ltd?
Gujarat Kidney and Super Speciality Ltd has the symbol GKSL and ISIN - INE0V0W01025.
What is the current price of Gujarat Kidney and Super Speciality Ltd?
Gujarat Kidney and Super Speciality Ltd is currently trading at INR 176.34.
What are the year high and year low of Gujarat Kidney and Super Speciality Ltd?
Gujarat Kidney and Super Speciality Ltd has a year high of INR 177.90 and a year low of INR 98.25.
What is the market capitalization of Gujarat Kidney and Super Speciality Ltd?
Gujarat Kidney and Super Speciality Ltd has a market capitalization of INR 1,010.37 crore.
What is the P/E ratio of Gujarat Kidney and Super Speciality Ltd?
Gujarat Kidney and Super Speciality Ltd has a P/E ratio of 47.44.
What is the dividend yield of Gujarat Kidney and Super Speciality Ltd?
Gujarat Kidney and Super Speciality Ltd has a dividend yield of 0.00%.
How is the financial performance of Gujarat Kidney and Super Speciality Ltd based on revenue, net income, and EPS?
Gujarat Kidney and Super Speciality Ltd has revenue of INR 82.01 crore, net income of INR 15.50 crore, and EPS of INR 2.14.
What is the book value of Gujarat Kidney and Super Speciality Ltd?
Gujarat Kidney and Super Speciality Ltd has a book value of INR 20.52.
What is the debt-to-equity ratio of Gujarat Kidney and Super Speciality Ltd?
Gujarat Kidney and Super Speciality Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Gujarat Kidney and Super Speciality Ltd?
Gujarat Kidney and Super Speciality Ltd has a price-to-book ratio of 8.59 and a price-to-sales ratio of 12.32.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.